{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:03Z","timestamp":1787020323252,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Seasonal malaria chemoprevention (SMC) involves administering antimalarial drugs at monthly intervals during the high malaria transmission period to children aged 3 to 59 months as recommended by the World Health Organization. Typically, a full SMC course is administered over four monthly cycles from July to October, coinciding with the rainy season. However, an analysis of rainfall patterns suggest that the malaria transmission season is longer and starting as early as June in the south of Burkina Faso, leading to a rise in cases prior to the first cycle. This study assessed the acceptability and feasibility of extending SMC from four to five cycles to coincide with the earlier rainy season in Mangodara health district.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The mixed-methods study was conducted between July and November 2019. Quantitative data were collected through end-of-cycle and end-of-round household surveys to determine the effect of the additional cycle on the coverage of SMC in Mangodara. The data were then compared with 22 other districts where SMC was implemented by Malaria Consortium. Eight focus group discussions were conducted with caregivers and community distributors and 11 key informant interviews with community, programme and national-level stakeholders. These aimed to determine perceptions of the acceptability and feasibility of extending SMC to five cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The extension was perceived as acceptable by caregivers, community distributors and stakeholders due to the positive impact on the health of children under five. However, many community distributors expressed concern over the feasibility, mainly due to the clash with farming activities in June. Stakeholders highlighted the need for more evidence on the impact of the additional cycle on parasite resistance prior to scale-up. End-of-cycle survey data showed no difference in coverage between five SMC cycles in Mangodara and four cycles in the 22 comparison districts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The additional cycle should begin early in the day in order to not coincide with the agricultural activities of community distributors. Continuous sensitisation at community level is critical for the sustainability of SMC and acceptance of an additional cycle, which should actively engage male caregivers. Providing additional support in proportion to the increased workload from a fifth cycle, including timely remuneration, is critical to avoid the demotivation of community distributors. Further studies are required to understand the effectiveness, including cost-effectiveness, of tailoring SMC according to the rainy season. Understanding the impact of an additional cycle on parasite resistance to SPAQ is critical to address key informants\u2019 concerns around the deviation from the current four-cycle policy recommendation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-022-12741-9","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:10:55Z","timestamp":1646439055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso"],"prefix":"10.1186","volume":"22","author":[{"given":"Adama","family":"Traore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Counihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Ragnessi","family":"Savadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"12741_CR1","doi-asserted-by":"publisher","DOI":"10.30875\/60123dd4-en","volume-title":"World malaria report 2020: 20 years of global progress and challenges","author":"Organization\u2019 WH","year":"2020","unstructured":"Organization\u2019 WH. World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020."},{"issue":"12","key":"12741_CR2","doi-asserted-by":"publisher","first-page":"e1595","DOI":"10.1016\/S2214-109X(19)30420-6","volume":"7","author":"M Accrombessi","year":"2019","unstructured":"Accrombessi M, Issifou S. Malaria control and elimination in sub-Saharan Africa: data from antenatal care centres. Lancet Glob Health. 2019;7(12):e1595\u2013e6.","journal-title":"Lancet Glob Health"},{"key":"12741_CR3","unstructured":"Institut National de la Statistique et de la D, Programme d'Appui au D\u00e9veloppement S, Programme National de Lutte contre le P, Icf. Burkina Faso malaria indicator survey 2017-2018. Ouagadougou: INSD, Burkina Faso, PADS, PNLP, and ICF; 2018."},{"key":"12741_CR4","unstructured":"Minist\u00e8re de l\u2019\u00e9conomie et des finances, cinqui\u00e8me r\u00e9censement g\u00e9n\u00e9ral de la population et de l\u2019habitat: r\u00e9sultats preliminaires, Ouagadougou, INSD, 2020, 76 pages."},{"key":"12741_CR5","unstructured":"WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). 2014."},{"key":"12741_CR6","unstructured":"WHO policy recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. 2012."},{"key":"12741_CR7","doi-asserted-by":"crossref","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;(2).","DOI":"10.1002\/14651858.CD003756.pub4"},{"issue":"11","key":"12741_CR8","doi-asserted-by":"publisher","first-page":"e0187460","DOI":"10.1371\/journal.pone.0187460","volume":"12","author":"R Compaor\u00e9","year":"2017","unstructured":"Compaor\u00e9 R, Yameogo MWE, Millogo T, Tougri H, Kouanda S. Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso. PLoS One. 2017;12(11):e0187460.","journal-title":"PLoS One"},{"key":"12741_CR9","doi-asserted-by":"crossref","unstructured":"Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396(10265):1829-40.","DOI":"10.1016\/S0140-6736(20)32525-3"},{"issue":"2","key":"12741_CR10","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S2214-109X(20)30475-7","volume":"9","author":"C Gilmartin","year":"2021","unstructured":"Gilmartin C, Nonvignon J, Cairns M, Milligan P, Bocoum F, Winskill P, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis. Lancet Glob Health. 2021;9(2):e199\u2013208.","journal-title":"Lancet Glob Health"},{"key":"12741_CR11","unstructured":"INSTECH, 2020, Rapport final Enqu\u00eate de couverture 2019, Bobo-Dioulasso, 22 pages."},{"key":"12741_CR12","unstructured":"Minist\u00e8re de la sant\u00e9, donn\u00e9es des cas de paludisme dans le district de Mangodara de 2016 \u00e0 2018), 2019."},{"key":"12741_CR13","unstructured":"Minist\u00e8re de la sant\u00e9, Annuaire statistique 2018, DGESS, Ouagadougou, 2019, 502 pages."},{"issue":"2","key":"12741_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/tmi.12642","volume":"21","author":"H Tagbor","year":"2016","unstructured":"Tagbor H, Antwi GD, Acheampong PR, Bart Plange C, Chandramohan D, Cairns M. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial. Tropical Med Int Health. 2016;21(2):224\u201335.","journal-title":"Tropical Med Int Health"},{"issue":"10","key":"12741_CR15","doi-asserted-by":"publisher","first-page":"e0162563","DOI":"10.1371\/journal.pone.0162563","volume":"11","author":"JL Ndiaye","year":"2016","unstructured":"Ndiaye JL, Ciss\u00e9 B, Ba EH, Gomis JF, Ndour CT, Molez JF, et al. Safety of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine when delivered to children under 10 years of age by District Health Services in Senegal: results from a stepped-wedge cluster randomized trial. PLoS ONE. 2016;11(10):e0162563.","journal-title":"PLoS ONE"},{"issue":"11","key":"12741_CR16","doi-asserted-by":"publisher","first-page":"e0166951","DOI":"10.1371\/journal.pone.0166951","volume":"11","author":"GD Antwi","year":"2016","unstructured":"Antwi GD, Bates LA, King R, Mahama PR, Tagbor H, Cairns M, et al. Facilitators and barriers to uptake of an extended seasonal malaria chemoprevention programme in Ghana: a qualitative study of caregivers and community health workers. PLoS ONE. 2016;11(11):e0166951.","journal-title":"PLoS ONE"},{"issue":"6","key":"12741_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00382-011-1276-x","volume":"39","author":"B Ibrahim","year":"2012","unstructured":"Ibrahim B, Polcher J, Karambiri H, Rockel B. Characterization of the rainy season in Burkina Faso and it\u2019s representation by regional climate models. Clim Dyn. 2012;39(6):1287\u2013302.","journal-title":"Clim Dyn"},{"key":"12741_CR18","unstructured":"Institut National de la Statistique et de la D\u00e9mographie (INSD), ICF. Enqu\u00eate sur les indicateurs du paludisme au Burkina Faso 2017-2018. Rockville. 2018."},{"key":"12741_CR19","unstructured":"Consortium M. Seasonal malaria chemoprevention program 2019-2020: Malaria Consortium\u2019s annual report on the use of philanthropic funding for seasonal malaria chemoprevention. 2019-2020."},{"key":"12741_CR20","unstructured":"2019 coverage report: seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. 2020."},{"issue":"1","key":"12741_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12936-017-1982-x","volume":"16","author":"AS Ali","year":"2017","unstructured":"Ali AS, Thawer NG, Khatib B, Amier HH, Shija J, Msellem M, et al. Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar. Malar J. 2017;16(1):332.","journal-title":"Malar J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-12741-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-12741-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-12741-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:12:06Z","timestamp":1646439126000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-12741-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["12741"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-12741-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-712597\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Comit\u00e9 Institutionnel de Bio\u00e9thique of Centre National de Recherche et de Formation sur le Paludisme (Burkina Faso) on 1<sup>st<\/sup> August 2019, reference: n\u00b02019\/000005\/MS\/SG\/INSP\/CNRFP\/CIB. All respondents provided informed consent for their participation in the study. The study protocol was created and conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}